Apex BioTechnology Corp.
MODIFICATION TO GLUCOSURE BGM SYSTEM, MODEL 221100
SKU K011233UPC CGA
In Stock
—
IIFDA 510(k) Cleared (K011233)
1
Free shipping on orders over $99 · 30-day returns
Apex BioTechnology Corp.
Free shipping on orders over $99 · 30-day returns
MODIFICATION TO GLUCOSURE BGM SYSTEM, MODEL 221100 is an FDA 510(k)-cleared medical device (K011233) manufactured by Apex BioTechnology Corp.. This device is classified under the Clinical Chemistry specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on May 17, 2001. Regulation: 8.
